Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients

Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients

Bibliographic Details
Main Authors: Dominika Wcisło-Dziadecka, Beniamin Grabarek, Celina Kruszniewska-Rajs, Andrzej Swinarew, Krzysztof Jasik, Beata Rozwadowska, Agata Krawczyk
Format: Article
Language:English
Published: Termedia Publishing House 2020-11-01
Series:Advances in Dermatology and Allergology
Subjects:
tumor necrosis factor a
treatment personalisation
mirna
anti-tnf therapy
psoriasis.
Online Access:https://www.termedia.pl/Analysis-of-molecular-and-clinical-parameters-of-4-year-r-nadalimumab-therapy-in-psoriatic-patients,7,42294,1,1.html

Internet

https://www.termedia.pl/Analysis-of-molecular-and-clinical-parameters-of-4-year-r-nadalimumab-therapy-in-psoriatic-patients,7,42294,1,1.html

Similar Items